【レポートの概要（一部）】
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Product Profiles
04.1.1 Enablex/Emselex
04.1.2 Gelnique
04.1.3 Oxytrol
04.1.4 Botox
04.1.5 Sanctura/ Sanctura XR
04.1.6 Myrbetriq
04.1.7 Vesicare
04.1.8 Detrol/Detrol LA
04.1.9 Toviaz
05. Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06. Introduction
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Molecule Type
08.1 Biologics
08.2 Small Molecules
09. Market Segmentation by Route of Administration
09.1 Oral
09.2 Parenteral
09.3 Topical
10. Market Segmentation by Class of drugs
10.1 Anti-muscarinic Agent
10.2 Beta-3-Adrenergic Receptor Agonist
11. Market Segmentation by Dosage Form
11.1 Solid
11.2 Liquid
11.3 Semisolid
11.4 Transdermal
12. Rate of Incidence and Prevalence
13. Geographical Segmentation
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2013
21.2.1 Actavis
21.2.2 Allergan
21.2.3 Astellas Pharma
21.2.4 Pfizer
21.3 Other and Future Prominent Vendors
22. Pipeline Portfolio
23. Key Vendor Analysis
23.1 Actavis plc
23.1.1 Key Facts
23.1.2 Business Description
23.1.3 Business Segmentation
23.1.4 Business Segmentation by Revenue 2012 and 2013
23.1.5 Sales by Geography
23.1.6 Business Strategy
23.1.7 Key Information
23.1.8 SWOT Analysis
23.2 Allergan Inc.
23.2.1 Key Facts
23.2.2 Business Description
23.2.3 Business Segmentation
23.2.4 Revenue by Business Segmentation
23.2.5 Revenue Comparison 2011-2013
23.2.6 Revenue by Geographical Segmentation
23.2.7 Business Strategy
23.2.8 Key Developments
23.2.9 SWOT Analysis
23.3 Astellas Pharma
23.3.1 Key Facts
23.3.2 Business Overview
23.3.3 Product Segmentation
23.3.4 Product Segmentation by Revenue 2012 and 2013
23.3.5 Geographical Segmentation by Revenue 2013
23.3.6 Business Strategy
23.3.7 Recent Developments
23.3.8 SWOT Analysis
23.4 Pfizer
23.4.1 Key Facts
23.4.2 Business Overview
23.4.3 Business Segmentation by Revenue 2013
23.4.4 Business Segmentation by Revenue 2012 and 2013
23.4.5 Geographical Segmentation by Revenue
23.4.6 Business Strategy
23.4.7 Key Developments
23.4.8 SWOT Analysis
24. Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Overactive Bladder Therapeutics Market 2013-2018 (US$ billion)
Exhibit 3: Global Overactive Bladder Therapeutics Market Segmentation by Molecule Type
Exhibit 4: Global Overactive Bladder Therapeutics Market Segmentation by Molecule Type 2013
Exhibit 5: Global Overactive Bladder Therapeutics Market Segmentation by Route of Administration
Exhibit 6: Global Overactive Bladder Therapeutics Market Segmentation by Route of Administration 2013
Exhibit 7: Global Overactive Bladder Therapeutics Market Segmentation by Class of Drugs
Exhibit 8: Global Overactive Bladder Therapeutics Market Segmentation by Class of Drugs 2013
Exhibit 9: Global Overactive Bladder Therapeutics Market Segmentation by Dosage Form
Exhibit 10: Global Overactive Bladder Therapeutics Market Segmentation by Dosage Form 2013
Exhibit 11: Global Overactive Bladder Therapeutics Market by Geographical Segmentation 2013
Exhibit 12: Global Overactive Bladder Therapeutics Market Share Analysis 2013
Exhibit 13: Prescription chart
Exhibit 14: By drugs prescribed (up to 2011)
Exhibit 15: YoY Sales Comparison of Botox 2008-2013 (in US$ million)
Exhibit 16: YoY Sales Comparison of Vesicare 2008-2013 (in US$ million)
Exhibit 17: YoY Sales Comparison of Vesicare in Japan 2008-2013 (in US$ million)
Exhibit 18: YoY Sales Comparison of Vesicare in the Americas 2008-2013 (in US$ million)
Exhibit 19: YoY Sales Comparison of Vesicare in Europe 2008-2013 (in US$ million)
Exhibit 20: YoY Sales Comparison of Vesicare in Asia 2008-2013 (in US$ million)
Exhibit 21: Sales Comparison of Vesicare 2008-2013 (in US$ million)
Exhibit 22: YoY Sales Comparison of Detrol/Detrol LA 2009-2013 (in US$ million)
Exhibit 23: YoY Sales Comparison of Toviaz 2009-2013 (in US$ million)
Exhibit 24: Pipeline Molecules for the Treatment of Overactive Bladder
Exhibit 25: Global Overactive Bladder Therapeutics Market Business Segmentation 2013
Exhibit 26: Global Overactive Bladder Therapeutics Market Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 27: Actavis Plc: Sales by Geography (in US$ million)
Exhibit 28: Allergan Inc.: Business Segmentation
Exhibit 29: Allergan Inc.: Revenue by Business Segmentation 2013
Exhibit 30: Allergan Inc.: Revenue Comparison by Business Segmentation 2011-2013 (US$ billion)
Exhibit 31: Allergan Inc.: Revenue by Geographical Segmentation 2013
Exhibit 32: Astellas Pharma: Product Segmentation 2013
Exhibit 33: Astellas Pharma: Product Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 34: Astellas Pharma: Geographical Segmentation by Revenue 2013
Exhibit 35: Pfizer: Business Segmentation by Revenue 2013
Exhibit 36: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 37: Pfizer: Geographical Segmentation by Revenue 2013
【レポート販売概要】
■ タイトル：過活動膀胱（OAB）治療薬の世界市場：抗ムスカリン剤、ß3アドレナリン受容体作動薬■ 英文：Global Overactive Bladder Therapeutics Market 2014-2018
■ 発行日：2014年11月5日
■ 調査会社：TechNavio
■ 商品コード：IRTNTR4514
■ 調査対象地域：グローバル
- 大腸癌治療薬の世界市場2015-2019About Colorectal Cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Colorectal cancer is the third most common cancer in the US. Some of …
- パルス酸素濃度計の世界市場の規模と予測：タイプ別（指先、ハンドヘルド、その他）、エンドユーザー別（病院・医療施設、ホームケア）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEA）、セグメント予測、2013-2025The global pulse oximeters market is expected to reach USD 2.8 billion by 2025, based on a new report by Grand View Research, Inc. The pulse oximeters market is anticipated to witness significant growth during the forecast period, which can be attributed to the growing prevalence of target diseases such as chronic obstructive pulmonary disease (COPD), sleep apnea, cardiac arrhythmia, and ischemic …
- RSウイルス（RSV）検査の世界市場2015The report presents a detailed analysis of the Respiratory Syncytial Virus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Respiratory Syncytial Virus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: …
- 世界のブラックペッパー市場2015The Global Black Pepper Industry Report 2015 is a professional and in-depth study on the current state of the Black Pepper industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Black Pepper market analysis is provided for the international markets including development trends, competitive landscape analy …
- 物理セキュリティの世界市場2018-2022About Physical Security Physical security is the protection of software, personnel, hardware, data, and networks from events that can cause damage to an organization. It helps enterprises by safeguarding them against fire, terrorism, vandalism, and theft. It can be done by using various physical security devices such as CCTV surveillance, access control protocols, intruder alarms, Video Surveillan …
- Gonorrhea：医療検査市場2014The report presents a detailed analysis of the Gonorrhea diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Gonorrhea definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Com …
- 世界のしゅう酸市場2015The Global Oxalic Acid Industry Report 2015 is a professional and in-depth study on the current state of the Oxalic Acid industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Oxalic Acid market analyses is provided for the international markets including development trends, competitive landscape analysi …
- 対話型システムの世界市場予測・分析2020-2024Global Conversational Systems Market: About this market Technavio’s conversational systems market analysis considers sales from both text and voice types. Our study also finds the sales of conversational systems in APAC, Europe, MEA, North America, and South America. In 2018, the text segment had a significant market share, and this trend is expected to continue over the forecast period. Factors s …
- OTT（Over-The-Top）規制動向Over the last decade a completely new economy has evolved based on the Internet and OTT players. While this had until recently been actively encouraged to galvanise the economy, there is now simply too much revenue involved for the players not to receive regulatory intervention. This report looks into such OTT regulatory landscape in the key areas of net neutrality, competition, tax optimization, …
- Familial Chylomicronemia (Type I Hyperlipoproteinemia)：治療薬のグローバル治験動向（2014年上半期）Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014" provides data on the Familial Chylomicronemia (Type I Hyperlipoproteinemia) clinical trial scenario. This report provides elemental information and data relating to …
- 航空貨物セキュリティ及びスクリーニング装置の世界市場About air cargo security and screening systems Security checks for cargo shipments are traditionally carried out through physical inspection by humans or canines (threat detection dogs). However, due to increase in global air cargo traffic, there is increased need for effective security and screening systems. Adoption of new sophisticated screening techniques that are more efficient and effective …
- 特殊テープの世界市場2019-2023About this market The construction industry is a major end-user of specialty tapes. Therefore, the growth in the global construction market is expected to drive the demand for specialty tapes for construction applications. The global housing market has been witnessing significant growth over the last three years, particularly in developed countries such as the US. The growth in the housing market …
- セノスフェアの世界市場予測（～2022年）：灰色セノスフェア、白色セノスフェア“The cenospheres market is projected to reach USD 689.2 million by 2022”The global cenospheres market was valued at USD 346.8 million in 2016 and is projected to reach USD 689.2 million by 2022, at a CAGR of 12.16% from 2017 to 2022. The growing demand from end-use industries, such as paints & coatings, refractory, construction, and oil & gas is expected to drive the market in near future. However …
- インビトロ毒物検査の世界市場予測（～2022年）“The global in vitro toxicology testing market is projected to grow at a CAGR of 6.6%.”The in vitro toxicology testing market is expected to reach USD 8.74 billion by 2022 from an estimated USD 6.34 billion in 2017, at a CAGR of 6.6%. The key factors driving the growth of this market include opposition to animal testing, growing demand for in vitro technology in the European market, new and promis …
- 慢性血栓塞栓性肺高血圧症（CTEPH）：治療薬のグローバル治験動向（2014年下半期）Chronic Thromboembolic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Chronic Thromboembolic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Chronic Thromboembolic Pulmonary Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chr …
